# Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone With Intensity-modulated Radiotherapy (IMRT) for Non Small Cell Lung Cancer (NSCLC) to an Individualised Mean Lung Dose (MLD)

> **NCT01166204** · PHASE2 · COMPLETED · sponsor: **Maastricht Radiation Oncology** · enrollment: 300 (actual)

## Conditions studied

- Stage I-III Non-small Cell Lung Cancer

## Interventions

- **RADIATION:** Radiotherapy

## Key facts

- **NCT ID:** NCT01166204
- **Lead sponsor:** Maastricht Radiation Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05
- **Primary completion:** 2017-05
- **Final completion:** 2017-05
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2017-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01166204

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01166204, "Concurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone With Intensity-modulated Radiotherapy (IMRT) for Non Small Cell Lung Cancer (NSCLC) to an Individualised Mean Lung Dose (MLD)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01166204. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*